Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis
Crossref DOI link: https://doi.org/10.1186/s12933-016-0356-y
Published Online: 2016-02-19
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sonesson, Christian
Johansson, Peter A.
Johnsson, Eva
Gause-Nilsson, Ingrid
Funding for this research was provided by:
AstraZeneca
